NIPH
ALXN

NN Investment Partners Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

NN Investment Partners Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-42,534
Closed -$7.81M – 888
2021
Q2 		$7.81M Buy
42,534
+1,986
+5% +$341K 0.04% 331
2021
Q1 		$6.2M Buy
40,548
+3,745
+10% +$579K 0.04% 362
2020
Q4 		$5.75M Buy
36,803
+5,253
+17% +$675K 0.03% 351
2020
Q3 		$3.61M Sell
31,550
-54
-0.2% -$5.83K 0.02% 411
2020
Q2 		$3.55M Buy
31,604
+184
+0.6% +$19.5K 0.02% 400
2020
Q1 		$2.82M Buy
31,420
+1,930
+7% +$189K 0.02% 402
2019
Q4 		$3.19M Buy
29,490
+672
+2% +$71.9K 0.02% 445
2019
Q3 		$2.82M Buy
28,818
+2,556
+10% +$288K 0.02% 416
2019
Q2 		$3.44M Buy
26,262
+922
+4% +$119K 0.03% 388
2019
Q1 		$3.43M Buy
25,340
+20,577
+432% +$2.56M 0.03% 401
2018
Q4 		$464K Buy
+4,763
New +$563K ﹤0.01% 631
2018
Q1 		– Sell
-1,279
Closed -$153K – 665
2017
Q4 		$153K Sell
1,279
-876
-41% -$107K ﹤0.01% 608
2017
Q3 		$302K Sell
2,155
-19,517
-90% -$2.65M ﹤0.01% 649
2017
Q2 		$2.64M Sell
21,672
-380
-2% -$44.2K 0.02% 326
2017
Q1 		$2.67M Sell
22,052
-3,147
-12% -$406K 0.03% 310
2016
Q4 		$3.08M Sell
25,199
-8,651
-26% -$1.06M 0.03% 296
2016
Q3 		$4.15M Buy
33,850
+3,000
+10% +$386K 0.04% 259
2016
Q2 		$3.6M Sell
30,850
-38,714
-56% -$5.49M 0.03% 267
2016
Q1 		$9.69M Buy
+69,564
New +$10.2M 0.09% 176

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

NN Investment Partners Holdings's ALXN Position: Q3 2021 in Review

NN Investment Partners Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 42,534 shares — an estimated $7.81M sold.

NN Investment Partners Holdings first reported a position in ALXN in Q1 2016 and held it in 19 quarters. The position peaked at $9.69M in Q1 2016. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • NN Investment Partners Holdings reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • NN Investment Partners Holdings sold 42,534 Alexion Pharmaceuticals shares in Q3 2021, an estimated $7.81M.
  • NN Investment Partners Holdings first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 19 quarters.
  • NN Investment Partners Holdings's Alexion Pharmaceuticals position peaked at $9.69M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on NN Investment Partners Holdings's 13F filing for Q3 2021, filed 10 Nov 2021.